Avelumab: Another active immune checkpoint inhibitor in nonsmall cell lung cancer

Hao Xie; Alex A. Adjei

doi:10.21037/tlcr.2017.10.15

Avelumab: Another active immune checkpoint inhibitor in nonsmall cell lung cancer

Hao Xie, Alex A. Adjei

Medical Oncology

Research output: Contribution to journal › Editorial › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	S41-S43
Journal	Translational Lung Cancer Research
Volume	6
DOIs	https://doi.org/10.21037/tlcr.2017.10.15
State	Published - Dec 1 2017

ASJC Scopus subject areas

Oncology

Access to Document

10.21037/tlcr.2017.10.15

Cite this

@article{fd49b59ee2014722925bec5ee8ecc805,

title = "Avelumab: Another active immune checkpoint inhibitor in nonsmall cell lung cancer",

author = "Hao Xie and Adjei, {Alex A.}",

year = "2017",

month = dec,

day = "1",

doi = "10.21037/tlcr.2017.10.15",

language = "English (US)",

volume = "6",

pages = "S41--S43",

journal = "Translational Lung Cancer Research",

issn = "2218-6751",

publisher = "Society for Translational Medicine (STM)",

}

TY - JOUR

T1 - Avelumab

T2 - Another active immune checkpoint inhibitor in nonsmall cell lung cancer

AU - Xie, Hao

AU - Adjei, Alex A.

PY - 2017/12/1

Y1 - 2017/12/1

UR - http://www.scopus.com/inward/record.url?scp=85038608456&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038608456&partnerID=8YFLogxK

U2 - 10.21037/tlcr.2017.10.15

DO - 10.21037/tlcr.2017.10.15

M3 - Editorial

AN - SCOPUS:85038608456

SN - 2218-6751

VL - 6

SP - S41-S43

JO - Translational Lung Cancer Research

JF - Translational Lung Cancer Research

ER -

Avelumab: Another active immune checkpoint inhibitor in nonsmall cell lung cancer

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this